The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.
Glioblastoma multiforme (GBM) is the most common and most aggressive malignant brain tumor. Despite optimal treatment and evolving standard of care, the median survival of patients diagnosed with GBM is only 12-15 months. In this study, we combined progesterone (PROG) and temozolomide (TMZ), a stand...
Main Authors: | Fahim Atif, Neil R Patel, Seema Yousuf, Donald G Stein |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4482510?pdf=render |
Similar Items
-
The Synergistic Effects of the Combination of Ciprofloxacin and Temozolomide on Human Glioblastoma A-172 Cell Line
by: Ashkan Zandi, et al.
Published: (2017-01-01) -
Synergistic Effects of Resveratrol and Temozolomide Against Glioblastoma Cells: Underlying Mechanism and Therapeutic Implications
by: Liu Y, et al.
Published: (2020-09-01) -
Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model
by: Véronique Mathieu, et al.
Published: (2008-12-01) -
Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
by: Hyungsin Kim, et al.
Published: (2019-09-01) -
Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells
by: Bernd Kaina, et al.
Published: (2020-09-01)